Item 2.06. Material Impairments

On June 9, 2021, Elanco Animal Health Incorporated ("Elanco") announced that it entered into a definitive agreement to sell its manufacturing sites in Shawnee, Kansas, and Speke, United Kingdom. Elanco anticipates a non-cash impairment charge of $245 to $305 million to be taken in the second quarter of 2021 related to these events, as the assets associated with these facilities will be classified as held for sale at quarter-end.

© Edgar Online, source Glimpses